Exact Mass: 338.0338

Exact Mass Matches: 338.0338

Found 49 metabolites which its exact mass value is equals to given mass value 338.0338, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Versicolorin A

4,6,8-Trihydroxy-3a,12a-dihydroanthra[2,3-b]furo[3,2-d]furan-5,10-dione

C18H10O7 (338.0427)

An organic heteropentacyclic compound that is 3a,12a-dihydroanthra[2,3-b]furo[3,2-d]furan-5,10-dione carrying three hydroxy substituents at positions 4, 6 and 8.

5,6-Dihydro-4-(2-methylpropyl)amino-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide

4-[(2-methylpropyl)amino]-1,1-dioxo-2H,3H,4H-1lambda6-thieno[2,3-b]thiopyran-6-sulfonamide

C11H18N2O4S3 (338.0429)

D004791 - Enzyme Inhibitors > D002257 - Carbonic Anhydrase Inhibitors

A naphthochromene that is 4H-naphtho[2,3-g]chromene-4,6,11-trione substituted by hydroxy groups at positions 5, 7 and 9 and a methyl group at position 2. It is isolated from fungal strains Phoma and Penicillium and acts as an inhibitor of the enzyme topoisomerase I. D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059004 - Topoisomerase I Inhibitors D004791 - Enzyme Inhibitors

3-Acetoxy-6H-[1,3]dioxolo[5,6]benzofuro[3,2-c][1]benzopyran-6-one

C18H10O7 (338.0427)

TOPOPYRONE C

C18H10O7 (338.0427)

A naphthochromene that is 4H-naphtho[2,3-h]chromene-4,7,12-trione substituted by hydroxy groups at positions 5, 9 and 11 and a methyl group at position 2. It is isolated from fungal strains Phoma and Penicillium and acts as an inhibitor of the enzyme topoisomerase I. D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059004 - Topoisomerase I Inhibitors D004791 - Enzyme Inhibitors

2,2-Oxybis(3-hydroxy-4H-1-benzopyran-4-one)

C18H10O7 (338.0427)

Saintopin

C18H10O7 (338.0427)

A member of the class of tetracenequinones that is tetracene-5,12-dione in which the hydrogens at positions 1, 3, 8, 10, and 11 have been replaced by hydroxy groups. Isolated from Paecilomyces.

Rubrifacine

C13H10N2O9 (338.0386)

Dehydrodigallic acid

C14H10O10 (338.0274)

Dehydrodigallensaeure

C14H10O10 (338.0274)

Bis(4-(trifluoroMethyl)phenyl)phosphine oxide

C14H9F6OP (338.0295)

thiapronil

C18H11ClN2OS (338.0281)

Triethyl 3-bromopropane-1,1,1-tricarboxylate

C12H19BrO6 (338.0365)

Brodimoprim

C13H15BrN4O2 (338.0378)

J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01EA - Trimethoprim and derivatives C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D000890 - Anti-Infective Agents

4-(3-BROMO-PHENYL)-6-METHYL-2-OXO-1,2,3,4-TETRAHYDRO-PYRIMIDINE-5-CARBOXYLIC ACID ETHYL ESTER

C14H15BrN2O3 (338.0266)

Fluquazone

C16H10ClF3N2O (338.0434)

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

3,3-Dimethoxy-4,4-biphenylbis(diazonium) dichloride

C14H12Cl2N4O2 (338.0337)

Benzo(b)thiophen-3-amine, 2-nitro-N-(3-(trifluoromethyl)phenyl)-

C15H9F3N2O2S (338.0337)

[1,1-Biphenyl]-4,4-bis(diazonium),3,3-dimethoxy-, chloride (1:2)

C14H12Cl2N4O2 (338.0337)

6H-1,3,2-Oxathiastannin-6-one,2,2-dibutyldihydro-

C11H22O2SSn (338.0362)

3-amino-6-phenyl-4-(trifluoromethyl)thieno[2,3-b]pyridine-2-carboxylic acid

C15H9F3N2O2S (338.0337)

Ellagic Acid Dihydrate

C14H10O10 (338.0274)

8-chloro-N-[4-(trifluoromethoxy)phenyl]quinolin-2-amine

C16H10ClF3N2O (338.0434)

COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS